Antibiotic—Lysobacter enzymogenes proteases combination as a novel virulence attenuating therapy

Minimizing antibiotic resistance is a key motivation strategy in designing and developing new and combination therapy. In this study, a combination of the antibiotics (cefixime, levofloxacin and gentamicin) with Lysobacter enzymogenes (L. enzymogenes) bioactive proteases present in the cell- free su...

Descripción completa

Detalles Bibliográficos
Autores principales: Suaifan, Ghadeer A. R. Y., Abdel Rahman, Diana M. A., Abu-Odeh, Ala’ M., Abu Jbara, Fahid, Shehadeh, Mayadah B., Darwish, Rula M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997937/
https://www.ncbi.nlm.nih.gov/pubmed/36893145
http://dx.doi.org/10.1371/journal.pone.0282705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997937/
https://www.ncbi.nlm.nih.gov/pubmed/36893145
http://dx.doi.org/10.1371/journal.pone.0282705

Ejemplares similares